Multiple Bcl-2 family immunomodulators from Vaccinia virus regulate MAPK/AP-1 activation

Journal of General Virology

Volumn 97, Issue 9, 2016, Pages 2346-2351

  Torres, Alice A ^a,b   Albarnaz, Jonas D ^b   Bonjardim, Cláudio A ^a   Smith, Geoffrey L ^b  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

AP 1; Bcl 2 family; Immune evasion; MAP kinase; NF kB; Vaccinia virus

Indexed keywords

IMMUNOMODULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; TRANSCRIPTION FACTOR AP 1; IMMUNOLOGIC FACTOR; VIRAL PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; REGULATORY MECHANISM; REPORTER GENE; VACCINIA VIRUS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

HOST-PATHOGEN INTERACTIONS; IMMUNOLOGIC FACTORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 84988856993     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000525     Document Type: Article

References (41)

1. Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J. & Kenney, S. (2000). Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 74, 1224-1233.
2. Andrade, A. A., Silva, P. N., Pereira, A. C., De Sousa, L. P., Ferreira, P. C., Gazzinelli, R. T., Kroon, E. G., Ropert, C. & Bonjardim, C. A. (2004). The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem J 381, 437-446.
3. Arthur, J. S. & Ley, S. C. (2013). Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13, 679-692.
4. Bartlett, N., Symons, J. A., Tscharke, D. C. & Smith, G. L. (2002). The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol 83, 1965-1976.
5. Benfield, C. T., Ren, H., Lucas, S. J., Bahsoun, B. & Smith, G. L. (2013). Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol 94, 1647-1657.
6. Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K. & O’Neill, L. A. (2000). A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc Natl Acad Sci U S A 97, 10162-10167.
7. Cargnello, M. & Roux, P. P. (2011). Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75, 50-83.
8. Chen, R. A., Jacobs, N. & Smith, G. L. (2006). Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol 87, 1451-1458.
9. Chen, R. A., Ryzhakov, G., Cooray, S., Randow, F. & Smith, G. L. (2008). Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog 4, e22.
10. Cooray, S., Bahar, M. W., Abrescia, N. G., McVey, C. E., Bartlett, N. W., Chen, R. A., Stuart, D. I., Grimes, J. M. & Smith, G. L. (2007). Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 88, 1656-1666.
11. Cowan, K. J. & Storey, K. B. (2003). Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 206, 1107-1115.
12. de Magalhães, J. C., Andrade, A. A., Silva, P. N., Sousa, L. P., Ropert, C., Ferreira, P. C., Kroon, E. G., Gazzinelli, R. T. & Bonjardim, C. A. (2001). A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. J Biol Chem 276, 38353-38360.
13. Fahy, A. S., Clark, R. H., Glyde, E. F. & Smith, G. L. (2008). Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol 89, 2377-2387.
14. Fedosyuk, S., Grishkovskaya, I., de Almeida Ribeiro, E. & Skern, T. (2014). Characterization and structure of the vaccinia virus NF-kB antagonist A46. J Biol Chem 289, 3749-3762.
15. Graham, S. C., Bahar, M. W., Cooray, S., Chen, R. A.-J., Whalen, D. M., Abrescia, N. G. A., Alderton, D., Owens, R. J., Stuart, D. I. & other authors (2008). Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog 4, e1000128.
16. Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A. & O’Neill, L. A. (2003). The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med 197, 343-351.
17. Kalverda, A. P., Thompson, G. S., Vogel, A., Schröder, M., Bowie, A. G., Khan, A. R. & Homans, S. W. (2009). Poxvirus K7 protein adopts a Bcl-2 fold: biochemical mapping of its interactions with human DEAD box RNA helicase DDX3. J Mol Biol 385, 843-853.
18. Keating, S. E., Maloney, G. M., Moran, E. M. & Bowie, A. G. (2007). IRAK-2 participates in multiple Toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem 282, 33435-33443.
19. Kyriakis, J. M. & Avruch, J. (2012). Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 92, 689-737.
20. Lee, Y. H., Chiu, Y. F., Wang, W. H., Chang, L. K. & Liu, S. T. (2008). Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta. J Gen Virol 89, 2437-2446.
21. Liu, X. & Cohen, J. I. (2016). Epstein-Barr virus (EBV) tegument protein BGLF2 promotes EBV reactivation through activation of the p38 mitogen-activated protein kinase. J Virol 90, 1129-1138.
22. Maloney, G., Schröder, M. & Bowie, A. G. (2005). Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10. J Biol Chem 280, 30838-30844.
23. Mansur, D. S., Maluquer de Motes, C., Unterholzner, L., Sumner, R. P., Ferguson, B. J., Ren, H., Strnadova, P., Bowie, A. G. & Smith, G. L. (2013). Poxvirus targeting of E3 ligase b-TrCP by molecular mimicry: a mechanism to inhibit NF-kB activation and promote immune evasion and virulence. PLoS Pathog 9, e1003183.
24. McFadden, G. (2005). Poxvirus tropism. Nat RevMicrobiol 3, 201-213.
25. Meng, Q. & Xia, Y. (2011). c-Jun, at the crossroad of the signaling network. Protein Cell 2, 889-898.
26. Neidel, S., Maluquer de Motes, C., Mansur, D. S., Strnadova, P., Smith, G. L. & Graham, S. C. (2015). Vaccinia virus protein A49 is an unexpected member of the B-cell Lymphoma (Bcl)-2 protein family. J Biol Chem 290, 5991-6002.
27. Oda, S., Schröder, M. & Khan, A. R. (2009). Structural basis for targeting of human RNA helicase DDX3 by poxvirus protein K7. Structure 17, 1528-1537.
28. Parkinson, J. E. & Smith, G. L. (1994). Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology 204, 376-390.
29. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K. & Cobb, M. H. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22, 153-183.
30. Pereira, A. C., Leite, F. G., Brasil, B. S., Soares-Martins, J. A., Torres, A. A., Pimenta, P. F., Souto-Padrón, T., Traktman, P., Ferreira, P. C. & other authors (2012). A vaccinia virus-driven interplay between the MKK4/7-JNK1/2 pathway and cytoskeleton reorganization. J Virol 86, 172-184.
31. Postigo, A., Martin, M. C., Dodding, M. P. & Way, M. (2009). Vacciniainduced epidermal growth factor receptor-MEK signalling and the antiapoptotic protein F1L synergize to suppress cell death during infection. Cell Microbiol 11, 1208-1218.
32. Santos, C. R., Blanco, S., Sevilla, A. & Lazo, P. A. (2006). Vaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signaling. J Virol 80, 7667-7675.
33. Schweneker, M., Lukassen, S., Späth, M., Wolferstätter, M., Babel, E., Brinkmann, K., Wielert, U., Chaplin, P., Suter, M. & other authors (2012). The vaccinia virus O1 protein is required for sustained activation of extracellular signal-regulated kinase 1/2 and promotes viral virulence. J Virol 86, 2323-2336.
34. Silva, P. N., Soares, J. A., Brasil, B. S., Nogueira, S. V., Andrade, A. A., de Magalhães, J. C., Bonjardim, M. B., Ferreira, P. C., Kroon, E. G. & other authors (2006). Differential role played by the MEK/ERK/EGR-1 pathway in orthopoxviruses vaccinia and cowpox biology. Biochem J 398, 83-95.
35. Smith, G. L., Benfield, C. T., Maluquer de Motes, C., Mazzon, M., Ember, S. W., Ferguson, B. J. & Sumner, R. P. (2013). Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol 94, 2367-2392.
36. Stack, J. & Bowie, A. G. (2012). Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions. J Biol Chem 287, 22672-22682.
37. Stack, J., Haga, I. R., Schröder, M., Bartlett, N. W., Maloney, G., Reading, P. C., Fitzgerald, K. A., Smith, G. L. & Bowie, A. G. (2005). Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201, 1007-1018.
38. Stack, J., Hurst, T. P., Flannery, S. M., Brennan, K., Rupp, S., Oda, S., Khan, A. R. & Bowie, A. G. (2013). Poxviral protein A52 stimulates p38 mitogen-activated protein kinase (MAPK) activation by causing tumor necrosis factor receptor-associated factor 6 (TRAF6) selfassociation leading to transforming growth factor b-activated kinase 1 (TAK1) recruitment. J Biol Chem 288, 33642-33653.
39. Sumner, R. P., Maluquer de Motes, C., Veyer, D. L. & Smith, G. L. (2014). Vaccinia virus inhibits NF-kB-dependent gene expression downstream of p65 translocation. J Virol 88, 3092-3102.
40. Unterholzner, L., Sumner, R. P., Baran, M., Ren, H., Mansur, D. S., Bourke, N. M., Randow, F., Smith, G. L. & Bowie, A. G. (2011). Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog 7, e1002247.
41. Whitmarsh, A. J. & Davis, R. J. (1996). Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74, 589-607.